Rockfield Stephanie, Kee Younghoon, Nanjundan Meera
Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, USA.
Oncogenesis. 2019 Aug 21;8(9):46. doi: 10.1038/s41389-019-0154-y.
Mechanisms underlying the pathogenesis of high-grade serous epithelial ovarian cancers (HGSOC) are not yet well defined although key precursor cells have been identified (including fimbriated fallopian tube epithelium, FTSECs). Since iron is elevated in endometriotic cysts and the pelvic cavity, it is suggested that this source of redox-active iron may contribute to ovarian cancer pathogenesis. Specifically, sources of nontransferrin-bound iron (NTBI) within the pelvic cavity could arise from ovulation, retrograde menstruation, follicular fluid, or iron overload conditions (i.e., hemochromatosis). Herein, we investigated the cellular response of p53-inactivated and telomerase-expressing (immortalized) FTSECs (Pax8/FoxJ1) to NTBI (presented as ferric ammonium citrate (FAC), supplemented in media for >2 months) in order to assess its ability to promote the transition to a tumor-like phenotype; this cellular response was compared with immortalized FTSECs transformed with H-Ras and c-Myc. Both approaches resulted in increased cell numbers and expression of the oncogenic transcriptional regulator, ecotropic virus integration site 1 (EVI1, a gene most frequently amplified at 3q26.2 in HGSOC, represented by multiple variants), along with other oncogenic gene products. In contrast to the transformed cells, FAC-exposed FTSECs elicited elevated migratory capacity (and epithelial-mesenchymal transition mRNA profile) along with increased expression of DNA damage response proteins (i.e., FANCD2) and hTERT mRNA relative to controls. Interestingly, in FAC-exposed FTSECs, EVI1 siRNA attenuated hTERT mRNA expression, whereas siRNAs targeting β-catenin and BMI1 (both elevated with chronic iron exposure) reduced Myc and Cyclin D1 proteins. Collectively, our novel findings provide strong foundational evidence for potential iron-induced initiation events, including EVI1 alterations, in the pathogenesis of HGSOC, warranting further in depth investigations. Thus, these findings will substantially advance our understanding of the contribution of iron enriched within the pelvic cavity, which may identify patients at risk of developing this deadly disease.
尽管已经确定了关键的前体细胞(包括输卵管纤毛上皮细胞,FTSECs),但高级别浆液性上皮性卵巢癌(HGSOC)发病机制背后的机制尚未完全明确。由于子宫内膜异位囊肿和盆腔中铁含量升高,有人提出这种具有氧化还原活性的铁源可能有助于卵巢癌的发病机制。具体而言,盆腔内非转铁蛋白结合铁(NTBI)的来源可能来自排卵、逆行月经、卵泡液或铁过载情况(即血色素沉着症)。在此,我们研究了p53失活且表达端粒酶(永生化)的FTSECs(Pax8/FoxJ1)对NTBI(以柠檬酸铁铵(FAC)形式呈现,在培养基中添加>2个月)的细胞反应,以评估其促进向肿瘤样表型转变的能力;将这种细胞反应与用H-Ras和c-Myc转化的永生化FTSECs进行比较。两种方法都导致细胞数量增加以及致癌转录调节因子嗜亲性病毒整合位点1(EVI1,一种在HGSOC中最常在3q26.2处扩增的基因,由多个变体代表)和其他致癌基因产物的表达增加。与转化细胞相比,暴露于FAC的FTSECs引发了更高的迁移能力(以及上皮-间质转化mRNA谱),同时相对于对照,DNA损伤反应蛋白(即FANCD2)和hTERT mRNA的表达增加。有趣的是,在暴露于FAC的FTSECs中,EVI1 siRNA减弱了hTERT mRNA的表达,而靶向β-连环蛋白和BMI1(两者均随着慢性铁暴露而升高)的siRNAs降低了Myc和细胞周期蛋白D1蛋白。总的来说,我们的新发现为HGSOC发病机制中潜在的铁诱导起始事件(包括EVI1改变)提供了有力的基础证据,值得进一步深入研究。因此,这些发现将极大地推进我们对盆腔内富集铁的贡献的理解,这可能识别出有患这种致命疾病风险的患者。